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The 2-integrin LFA-1 facilitates extravasation of monocytes (MOs) into the underlying tissues, where MOs can differentiate
into dendritic cells (DCs). Although DCs express LFA-1, unlike MOs, they cannot bind to ICAM-1. We hypothesized that an
altered integrin organization on the DC plasma membrane might cause this effect and investigated the relationship between
membrane organization and function of LFA-1 on MOs and DCs. High-resolution mapping of LFA-1 surface distribution
revealed that on MOs LFA-1 function is associated with a distribution in well-defined nanoclusters (100–150-nm diameter).
Interestingly, a fraction of these nanoclusters contains primed LFA-1 molecules expressing the specific activation-dependent
L16-epitope. Live imaging of MO–T-cell conjugates showed that only these primed nanoclusters are dynamically recruited to
the cellular interface forming micrometer-sized assemblies engaged in ligand binding and linked to talin. We conclude that
besides affinity regulation, LFA-1 function is controlled by at least three different avidity patterns: random distributed inactive
molecules, well-defined ligand-independent proactive nanoclusters, and ligand-triggered micrometer-sized macroclusters.
INTRODUCTION
Integrins are transmembrane / heterodimers that regulate
cell–cell and cell–extracellular matrix interactions. Lympho-
cyte function-associated antigen-1 (LFA-1; L2; CD11a/
CD18) is a leukocyte specific integrin that mediates migration
across the endothelium and within tissues and formation of
immunological synapse (Dustin and Springer, 1989; van Kooyk
et al., 1989; Lub et al., 1995; Grakoui et al., 1999; Carman et al.,
2003). LFA-1 binds to its major counterreceptor ICAM-1 (Mar-
lin and Springer, 1987) and with lower affinity also to ICAM-2
(Staunton et al., 1989) and -3 (de Fougerolles et al., 1991; de
Fougerolles and Springer, 1992).
Two not-mutually-exclusive mechanisms were proposed ex-
plaining how integrins such as LFA-1 become activated. First,
conformational changes lead to an increased affinity for the
ligands (Shimaoka et al., 2003). Evidence comes from mutagen-
esis studies (Lu et al., 2001a; Lu et al., 2001b) and from the
identification of “activation reporter” epitopes (Dransfield and
Hogg, 1989; Beals et al., 2001). Indeed, NMR and negative stain
electron microscopy (EM) have revealed conformational rear-
rangement and movement, such as separation of the cytoplas-
mic tails and extension of the extracellular domains, that lead
to a general mechanism of integrin activation (Takagi et al.,
2002; Vinogradova et al., 2002). Early studies also showed that
a Ca2-dependent epitope recognized by the monoclonal an-
tibody (mAb) NKI-L16 (Keizer et al., 1988; van Kooyk et al.,
1991)—further referred to as L16 epitope—is an activation-
reporter epitope resulting from a Ca2-bound extended con-
formation of the L subunit (Xie et al., 2004).
A second mechanism that regulates integrin activation is a
dynamic reorganization of LFA-1 receptors into multimo-
lecular assemblies at the cell surface that locally increase the
binding valency (avidity; van Kooyk et al., 1999; Katagiri et
al., 2003). So far, experimental evidence for the formation of
such LFA-1 clusters on activated cells is limited and primar-
ily is based on images of micrometer-sized patches of mol-
ecules on the plasma membrane of polarized cells (van
Kooyk et al., 1994). Whether the formation of integrin clus-
ters precedes or follows ligand binding remains controver-
sial (Bazzoni and Hemler, 1998; Carman and Springer, 2003).
It was shown that on T-lymphocytes recruitment of LFA-1
within specialized membrane lipid microdomains enhances
LFA-1 clustering (Krauss and Altevogt, 1999; Marwali et al.,
2003), which might have direct implications for LFA-1 as a
signaling molecule (Leitinger and Hogg, 2002).
Human monocytes (MOs) use LFA-1 to mediate antibody
(Ab)-dependent cytotoxicity, to adhere to endothelial cells
and extravasate into the underlying tissue (Martz, 1987;
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Springer, 1990). Recently, endothelial cells were shown to
form upright microvilli-like projections that are enriched in
ICAM-1 molecules (Carman et al., 2003). Transmigrating
MOs present regions of increased density of LFA-1 mole-
cules that form linear clusters and colocalize with the ICAM-
1–enriched projections (Carman et al., 2003). As precursors
of antigen-presenting immature dendritic cells (DCs;
Banchereau and Steinman, 1998), MOs can differentiate in
DCs upon reverse transmigration over endothelial monolay-
ers (Randolph et al., 1998) or when cultured in vitro in
presence of GM-CSF and IL-4 (moDCs; Romani et al., 1996).
Although moDCs express LFA-1, unlike MOs, adhesion to
ICAM-2 and -3 is completely mediated by the C-type lectin
DC-SIGN (CD209; Geijtenbeek et al., 2000a, 2000b).
These observations suggest that the plasma membrane or-
ganization of adhesion receptors on MOs and DCs must
change dynamically, along with the specific alterations occur-
ring during the development from precursors toward DCs.
Our previous studies showed that distribution of DC-SIGN at
the cell surface dynamically changed during DC development
along with its binding properties (Cambi et al., 2004). This
prompted us to investigate and compare the relationship be-
tween cell membrane organization and adhesiveness of LFA-1
on MOs and DCs. Here, we demonstrate that LFA-1–mediated
binding to ICAM-1 is completely lost during development of
moDCs. This coincides with gradual exclusion of LFA-1 from
lipid microdomains. We used high-resolution transmission EM
(TEM) on whole-mount samples of MOs and DCs to map the
cell surface distribution of LFA-1 at submicrometer level. Our
findings demonstrate the existence of three levels of avidity for
LFA-1: randomly distributed inactive molecules, well-defined
ligand-independent nanoclusters, and ligand-triggered micro-
meter-sized macroclusters.
MATERIALS AND METHODS
Monoclonal Antibodies and Chemicals
The mouse mAbs against L chain: NKI-L15, NKI-L16, and TS2/4 (kindly
provided by E. Martz). Activating KIM185, kindly provided by M. Robinson,
Celltech (Slough, United Kingdom), and the blocking NKI-L19 recognize the
2 chain. REK-1 is a mAb anti-ICAM-1. CD46 and CD55 were detected by
E4.3 (PharMingen) and 143–30 (CLB, Amsterdam, The Netherlands), respec-
tively. Alexa-conjugated secondary Abs, Alexa-488–conjugated cholera toxin
B subunit, and the Alexa-647 labeling kit were from Molecular Probes (Eu-
gene, OR) and Invitrogen; methyl--cyclodextrin (MCD) from Sigma (St.
Louis, MO); rhodamine-conjugated goat anti-mouse IgG H&L Fab fragment
from Abcam (Cambridge, United Kingdom); goat anti-CTxB antibody from
Calbiochem (La Jolla, CA); goat anti-mouse-conjugated 10-nm gold from Au-
rion Biosystems (Vienna, Austria). The rat anti-cytohesin-1 Ab 7H2 was a gift
of W. Kolanus (University of Bonn, Germany). The rat anti-RAPL Ab E11.2
was a gift of K. Katagiri (Kyoto University, Japan).
Cells
MOs were obtained from buffy coats of healthy individuals and were purified
using Ficoll density centrifugation. Immature DCs were obtained as already
reported elsewhere (Romani et al., 1994; Geijtenbeek et al., 2000c). The Jurkat
T-cell line was kept in culture in Iscove’s medium supplemented with 5% fetal
calf serum.
Fluorescent Bead Adhesion Assay
Carboxylate-modified streptavidin-coated TransFluorSpheres (488/645 nm, 1
m A; Molecular Probes) were coated with ICAM-1-Fc, and the bead adhe-
sion assay was performed as described (Geijtenbeek et al., 1999). Briefly, the
fluorescent beads were coated with biotinylated goat anti-human Fc antbod-
ies and subsequently with ICAM-1-Fc chimeras. This guarantees the out-
wards orientation of the ICAM-1 molecules with respect to the bead surface.
After each coating step, several thorough washing steps ensure that the excess
of unbound molecules is washed away. For the incubation, a ratio of 20 beads
per cell was used. The blocking or stimulating Abs were preincubated with
the cells before adding the ligand-coated beads. When the lipid raft–disrupt-
ing agent MCD was used, the cells were resuspended in serum-free medium
containing 20 mM MCD and preincubated for 30 min at 37°C. Adhesion was
determined as the percentage of cells that bound fluorescent beads by flow
cytometry on an FAC-Scalibur (Becton Dickinson, Oxnard, CA).
Flow Cytometry
For flow cytometry analysis, cells were incubated (30 min, 4°C) in PBS, 0.5%
BSA, and 0.01% sodium azide, with different mAbs (5 g/ml), followed by
incubation with FITC-labeled goat anti-mouse IgG antibody (GAM-FITC;
Zymed, South San Francisco, CA) for 30 min at 4°C. The relative fluorescence
intensity was measured on a FACSCalibur. Isotype-specific controls were
included.
Confocal Microscopy
For studies of colocalization with lipid rafts, cells were stained with mAbs
and CTxB as already described (Cambi et al., 2004). Isotype-specific controls
were always included. Analysis was done with a Bio-Rad MRC1024 Confocal
Laser Scanning Microscope (Richmond, CA). Signals were collected sequen-
tially to avoid bleed-through. To prevent loss of NKI-L16 binding in the
double- or triple-labeling experiments, cells were not fixed before adding the
primary Abs. They were allowed to adhere on FN-coated coverslips and
stained with anti-LFA-1 (NKI-L16 or NKI-L15, or TS2/4) and anti-ICAM-1 (10
g/ml) at 4°C, after prolonged incubation in CLSM buffer to minimize a
specific binding. After removing unbound Abs by extensive washing in
ice-cold PBS, cells were quickly fixed in 1% PFA, and after a blocking step in
CLSM buffer, secondary staining for LFA-1 and ICAM-1 was performed using
isotype-specific Alexa-conjugated goat anti-mouse antibodies. Manders coef-
ficient M1 was calculated as already reported (Costes et al., 2004) and reflects
the amount of LFA-1 colocalizing with GM1 separately for each cell.
Electron Microscopy Labeling Procedure
For TEM, MOs and DCs were allowed to spread on glass coverslips covered
by a thin layer of poly-l-lysine (PLL)-coated Formvar for 1 h at 37°C, washed
to remove unbound cells, and immediately fixed with 1% PFA for 15 min.
Subsequent Ab and gold labeling was performed as already published
(Cambi et al., 2004). When labeling was performed using NKI-L16, no prefix-
ation with 1% PFA was performed to prevent loss of NKI-L16 binding.
Therefore, after adhesion on the substrate, cells were washed in ice-cold buffer
and incubated on ice with cold NKI-L16. Isotype-specific controls were al-
ways included. It should be noted that the effect of temperature changes on
NKI-L16 labeling is negligible (Supplementary Figure 2).
Analysis of Gold Particle Distribution Pattern
After gold labeling and fixation, the specimens were dehydrated and transferred
from the glass onto copper grids as already published (Cambi et al., 2004). The
specimens were observed in a JEOL 1010 transmission electron microscope
(Welwyn Garden City, United Kingdom), operating at 60–80 kV. Because MOs
and DCs widely spread, the membrane available for gold particle analysis
represented up to 60–70% of the whole labeled plasma membrane. For each cell
several areas were analyzed at random. The digital images of electron micro-
graphs were processed by custom-written software based on Labview (National
Instruments, Austin, TX) as already described (Cambi et al., 2004).
Live Imaging
MOs adhered onto a FN-coated glass Petri dish (30 min, 37°C). After extensive
washing in cold PBS, MOs were labeled with NKI-L16 (15 min, 4°C) and
subsequently with the rhodamine-conjugated goat anti-mouse IgG H&L Fab
fragment (15 min at 4°C). After thorough washing, the Alexa-647–conjugated
TS2/4 (or NKI-L15) was added for 15 min at RT. After washing in Imaging
medium (RPMI 1640, without phenol red), labeled MOs were put on the
microscope setup at 37°C and 5% CO2 for 10 min before imaging started.
Subsequently, unlabeled Jurkat T-cells were added, and the interactions were
analyzed with a Zeiss LSM 510 microscope, using a PlanApochromatic 63 
1.4 oil immersion DIC lens (Carl Zeiss GmbH, Jena, Germany). While record-
ing, the pinhole was completely open. Cells were imaged using Zeiss LSM
Image Browser version 3.2 (Carl Zeiss) and processed with Image J version
1.32j software (National Institutes of Health, http://rsb.info.nih.gov/ij).
RESULTS
LFA-1–mediated Binding Is Lost During Development of
moDCs
We previously showed that moDCs express high amounts of
DC-SIGN and moderate amounts of LFA-1. Both receptors are
able to bind to ICAM-2 and -3, additionally LFA-1 binds to
ICAM-1. While on MOs LFA-1 mediates adhesion to all
ICAMs, on DCs adhesion to ICAM-2 and -3 is completely
mediated by DC-SIGN (Geijtenbeek et al., 2000a, 2000b; Cambi
et al., 2004). In an attempt to understand this change in LFA-
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1–binding capacity from MOs to DCs, we measured LFA-1–
mediated binding to ICAM-1 Fc-coated beads during DC de-
velopment (Geijtenbeek et al., 1999). MOs and DCs profoundly
differ in their capacity to bind ICAM-1–coated fluorescent
beads (Figure 1A). More than 60% of MOs spontaneously
bound ICAM-1, and this interaction was predominantly 2-
integrin mediated, as shown by the effective block in the pres-
ence of anti-2 blocking mAb NKI-L19. The use of anti-L
blocking mAb (NKI-L15) indicated that on MOs, binding to
ICAM-1 was predominantly mediated by LFA-1 (40%), whereas
the other two 2-integrins MAC-1 and p150.95 mediated the
residual binding.
On differentiation of MOs into DCs, spontaneous binding to
ICAM-1 gradually decreased. On DCs, residual binding to
ICAM-1 was barely detectable and slightly inducible by the
anti-2–activating mAb KIM185. Similarly, other stimuli
known to activate LFA-1, such as Mn2, cytochalasin D, thap-
sigargin, or PMA, were unable to enhance LFA-1–binding
capacity (our unpublished data). Furthermore, no LFA-1–me-
diated binding was observed to soluble ICAM-1 molecules nor
to ICAM-1 coated onto a plate (our unpublished data), further
indicating that LFA-1 on DCs is unable to bind to its ligand
independently of the assay used. Any involvement of Fc re-
ceptors in the binding to ICAM-1 Fc was excluded by prein-
cubating the cells with a Fc receptor–blocking agent that
showed no effect in the bead assay (our unpublished data).
To exclude that the decreased binding to ICAM-1 on DCs
was due to decreased expression levels, we detected LFA-1
expression by flow cytometry. Figure 1B shows that LFA-1
expression levels, detected with the mAb NKI-L15, re-
mained unaltered during DC development.
The transition of LFA-1 from an inactive into an active
state is known to depend on extracellular Ca2 ions, and
Ca2 occupancy is reported by the  chain–specific mAb
NKI-L16, which detects the L16 epitope (Keizer et al., 1988;
van Kooyk et al., 1991, 1994). Recent studies more specifi-
cally showed that NKI-L16 recognizes a Ca2-bound ex-
tended conformation of the  subunit, typical of primed
LFA-1 (Xie et al., 2004). Therefore, we analyzed the L16
epitope expression on MOs and DCs. As shown in Figure 1B,
the L16 epitope was highly expressed on MOs but was
barely detectable on DCs.
It should be noted that the high expression level of the
other 2 integrins on both MOs and DCs prevented us from
analyzing other known activation reporter epitopes that in-
volve the 2 subunit to monitor LFA-1 activation state.
Together, these observations indicate that major changes
in LFA-1 adhesiveness occur during DC development.
Involvement of Lipid Rafts on LFA-1 Activity on MOs
and DCs
The recruitment of active LFA-1 into specific cholesterol-
and glycosphingolipids-enriched microdomains, known as
lipid rafts, was proposed as additional mechanism to regu-
late integrin activity (Krauss and Altevogt, 1999; Leitinger
and Hogg, 2002; Marwali et al., 2003). Therefore, we inves-
tigated whether lipid rafts played a role in LFA-1 adhesive-
ness on MOs and DCs.
On MOs, the effect of MCD, a lipid raft–disrupting agent
that extracts membrane cholesterol, was tested on the
ICAM-1 bead adhesion assay (Figure 2A). MCD treatment
inhibits binding for 40%, indicating that lipid raft disrup-
tion partially affected LFA-1–binding capacity. Furthermore,
we examined the codistribution of LFA-1 and the lipid raft
marker GM1, a glycosphingolipid, on MOs and DCs, by Ab
patching and confocal microscopy (Figure 2B). When cocap-
ping was induced on MOs, LFA-1 completely colocalized
with GM1 to the same extent as for the lipid raft–associated
GPI-anchored protein CD55. By contrast, on DCs, LFA-1 is
completely excluded from the lipid raft fraction.
Gradual exclusion of LFA-1 from these lipid microdo-
mains parallels the loss of L16 epitope and binding capacity.
Already after 3 d of monocyte differentiation, on the major-
ity of the cells, LFA-1 no longer colocalized with GM1 (our
unpublished data).
On MOs, we quantified the colocalization of either NKI-
L15 (total LFA-1) or NKI-L16 (primed LFA-1) with GM1 by
calculating the Manders coefficient (Costes et al., 2004). No
significant differences in colocalization with lipid rafts were
observed between primed and total LFA-1 (Figure 2C), sug-
gesting that on MO LFA-1 resides in lipid rafts even if the
molecule is not in the Ca2-bound extended primed confor-
mation. Finally, the colocalization coefficient for LFA-1 and
GM1 on DCs was found to be 0.14  0.24 (n  25), where 1
indicate full colocalization, thus indicating a significant ex-
clusion of LFA-1 from lipid raft domains on DCs.
LFA-1 Is Organized in Nanoclusters on MOs
The organization of the cell membrane has been described as
a mosaic of numerous lipid and protein microdomains rang-
ing from 20 to 500 nm (Mayor and Rao, 2004). The fact that
Figure 1. Binding to ICAM-1 and L16 epitope expression decrease
during development of moDCs. (A) Adhesion to ICAM-1 during
development of moDCs (see drawing) was determined using 1-m
ligand-coated fluorescent beads, prepared as described in Materials
and Methods. NKI-L15 and NKI-L19 mAbs were used to block LFA-1
and all 2 integrins, respectively. To enhance binding, the anti-2
activating mAb KIM185 was used. Neither blocking nor activation
was observed in presence of isotype controls (unpublished data).
One representative experiments out of three is shown. (B) The
expression levels of LFA-1 on MOs and DCs were assessed by FACS
analysis. , the isotype control; u, the specific staining with anti-
LFA-1 mAb. Mean fluorescence intensity is indicated. One repre-
sentative donor is shown.
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Figure 2. LFA-1 resides in lipid rafts on MOs, not on DCs. (A) LFA-1–mediated adhesion to ICAM-1–coated beads was measured on MOs
after cholesterol depletion by preincubation with 20 mM MCD for 30 min at 37°C. Data shown are means  SD of one representative
experiment (out of three) performed in triplicate. (B) Confocal microscopy analysis of copatching of LFA-1 (NKI-L15 labeled) and GM1 on
MOs and DCs. Receptor copatching and staining were performed as described in Material and Methods. CD55 and CD46 are positive and
negative lipid rafts marker, respectively. Results are representatives of multiple cells in three independent experiments. Bar, 5 m. (C) To
quantify the degree of colocalization between either NKI-L15 (total LFA-1) or NKI-L16 (primed LFA-1) with GM1 on MOs, the Manders
coefficient (M1) was calculated. M1 can vary between 0 and 1 (1  colocalization). Receptor copatching and staining were performed as
described in Material and Methods, and cells were analyzed by confocal microscopy (n  22).
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LFA-1 differentially associates with lipid rafts on MOs and
DCs (Figure 2) prompted us to investigate the cell mem-
brane organization of LFA-1 at high resolution.
We exploited TEM to study whole-mount samples of MOs
and DCs, after specific labeling of LFA-1 with gold particles.
Recently, we and others demonstrated the potential of this
method to map and quantitate the distribution patterns of
cell membrane receptors (Vereb et al., 2000; Panyi et al., 2003;
Cambi et al., 2004).
MOs and DCs were allowed to adhere and stretch before
labeling with mAb against LFA-1 and gold particles. It
should be noted that the stretched cells are so thin (down to
200 nm at cell periphery) that sectioning is not required, thus
making the whole dorsal membrane available for gold la-
beling and subsequent TEM analysis. To exclude any effect
of the substrate on LFA-1 distribution, TEM analysis was
also performed on cells that were gold-labeled in suspension
and then mounted onto PLL. No differences were seen be-
tween cells stretched on the support or cells adhering to PLL
(our unpublished data). We found that LFA-1 distribution
changed dramatically during DC development (Figure 3).
Although on MOs LFA-1 is organized in well-defined nano-
clusters, on DCs the gold particles are evenly distributed
over the cell surface.
To quantitatively describe LFA-1 distribution pattern,
nearest neighbor (nn) distance values among the gold par-
ticles were calculated applying spatial-point-pattern analy-
sis (Cambi et al., 2004). On MOs, almost 80% of the gold
particles resides within 50-nm distance from its nearest
neighbor (Figure 4A). In contrast, on DCs, nn distance val-
ues are almost equally distributed in all distance categories,
indicating no preferential organization of gold particles.
The relative partitioning of gold particles in clusters of var-
ious sizes (i.e., number of particles/cluster) was also quantified
(Figure 4B). Although on MOs only 20% of gold particles were
detected as single features, on DCs up to 70% of gold particles
were found as isolated single features on the cell membrane.
LFA-1 nanoclusters appear either as round or slightly elon-
gated features, with an indicative average diameter of 150 nm,
and are randomly localized on the cell. Similarly to NKI-L15,
NKI-L16 staining also showed clustered distribution of gold-
labeled LFA-1 on MO cell membrane (Figure 5A). However,
when LFA-1 was labeled by NKI-L16, the number of gold
particles per m2 was approximately fourfold lower when
compared with NKI-L15 labeled cells (Figure 5B). Labeling with
TS2/4 mAb, which recognizes another (inert) LFA-1 epitope,
gave results similar to NKI-L15 (our unpublished data).
To exclude that differences in the amount of gold particles
per m2 were due to differences in Ab labeling efficiency, we
also calculated the density of LFA-1 clusters on the cell
surface (Figure 5C). NKI-L16 labeled only one third of LFA-1
clusters detectable on MO cell membrane. Again, TS2/4
labeling gave similar results when compared with NKI-L15
(our unpublished data). In addition, all mAbs showed sim-
ilar distributions of nn distance values among gold particles
(Figure 5D) and comparable cluster sizes (Figure 5E). This
indicates that LFA-1 nanoclusters labeled by NKI-L16 are
similar to the NKI-L16 negative nanoclusters in terms of
density and size, but represent a primed fraction of LFA-1
that strongly binds Ca2 and is in an extended (primed)
conformation. MOs express LFA-1 and ICAM-1, facilitating
the formation of aggregates of cells. Because it was suggested
that ICAM-1 ligation might trigger LFA-1 microclusters forma-
tion (Kim et al., 2004), cells were seeded at low density to avoid
stimulation by homotypic aggregation and were extensively
washed allowing LFA-1 distribution to equilibrate before la-
beling for TEM was performed. Furthermore, inhibition of
LFA-1/ICAMs interactions in cis does not alter LFA-1 nano-
cluster organization (Supplementary Figure 3).
Therefore, on MO LFA-1 nanoclusters are formed in a
ligand-independent manner. Although most LFA-1 nano-
clusters are in a resting state, 25% are in a primed state
(L16 epitope expressed). Notably, L16 epitope expression is
confined to a subset of nanoclusters rather than equally
distributed over all clusters, suggesting the existence of clus-
ters representing distinct states of integrin activation. MO
differentiation into DC leads to complete dispersion of the
nanoclusters and subsequent random distribution of single
inactive LFA-1 molecules.
Primed LFA-1 Nanoclusters Readily Bind to ICAM-1
To further investigate the difference between primed and
resting LFA-1 nanoclusters, we performed double labeling
of LFA-1 using NKI-L16 and TS2/4 (nonoverlapping
epitopes). As shown in Figure 6A, all LFA-1 nanoclusters are
detectable by TS2/4, but only a subpopulation of these also
shows expression of the L16 epitope (indicated in yellow).
Interestingly, when MOs were seeded at high density,
Figure 3. LFA-1 is clustered on MOs and random on DCs. MOs
and DCs were specifically labeled with 10-nm gold and treated for
TEM (see Materials and Methods). Results represent multiple cells in
several independent experiments. The top pictures represent whole
cells imaged by TEM. Middle and bottom pictures are higher mag-
nifications where 10-nm gold particles are visible. Bar, 200 nm
unless otherwise indicated.
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primed L16 epitope expressing LFA-1 was specifically en-
riched at the contact zone between adjacent cells, indicating
that binding of ligand leads to preferential recruitment of
primed LFA-1 clusters (Figure 6B).
To test if the primed LFA-1 fraction at the contact site be-
tween adjacent cells was specifically involved in the binding to
ICAM-1 on the opposing cell, we allowed the formation of
conjugates between individual MOs and performed triple la-
beling to detect total LFA-1, primed LFA-1, and ICAM-1 si-
multaneously. The primed LFA-1 fraction completely colocal-
ized with ICAM-1 at the contact sites, forming macroclusters
up to a size of several micrometers (Figure 6C).
Although several proteins have been identified that bind
to the cytoplasmic tails of integrins (Liu et al., 2000), accu-
mulating evidence suggests that talin plays a central role in
activating LFA-1 (Kupfer and Singer, 1989; Monks et al.,
1998; Sampath et al., 1998). In verifying which cytoplasmic
regulators of LFA-1 were present at the contact sites, we
observed that LFA-1 macroclusters engaged in binding with
ICAM-1 completely colocalize with talin, which is clearly
enriched at the contact sites (Figure 6D). Although we did
not find a similar enrichment of other known regulators of
LFA-1 such as cytohesin-1 (Geiger et al., 2000) and RapL
(Katagiri et al., 2003; Figure 6, E and F), we cannot exclude
that these proteins may have either a transient or a weaker
role in regulating LFA-1 adhesion on MOs.
Next, we investigated whether the interaction of LFA-1
with talin is essential in the formation of primed nanoclus-
ters even in absence of ligand binding. Ligand-independent
Ab-induced capping of primed LFA-1 did not result in clear
colocalization of the cytoplasmic proteins talin, cytohesin,
and RapL, suggesting that the expression of the L16 epitope
is not the result of pre-existing ligand-independent associa-
tion of the cytoplasmic tails of LFA-1 with any of its known
regulators (Supplementary Figure 1).
From these results we conclude that on the cell membrane
of MO LFA-1 molecules are organized in nanoclusters
formed without prior engagement of ligand and indepen-
dent from known intracellular regulators such as talin.
Primed LFA-1 Nanoclusters Are Dynamically Recruited at
MO–T-cell Interface and Form Macroclusters
In an attempt to understand if these LFA-1 macroclusters
localized at the contact site between adjacent cells were
derived from the dynamic recruitment of pre-existing nano-
clusters of primed LFA-1, we analyzed contact formation
between MOs and T-cells in real time. Freshly isolated MOs
were allowed to adhere onto glass coverslips and prelabeled
with fluorescent mAb TS2/4 and with NKI-L16, which was
detected by a fluorescent secondary Fab fragment. After
washing unbound Abs, T-cells were added, and the forma-
tion of MO–T-cell conjugates was followed in time. It is
important to note that resting T-cells express ICAM-1 but do
not express the L16 epitope and do not spontaneously bind
to ICAM-1, indicating that on these T-cells LFA-1 is resting
(our unpublished data). In Figure 7A, a clear enrichment of
Figure 4. Quantitative analysis of the distribution
of gold particles labeling LFA-1. The digital images
were processed by a custom-written software based
on Labview. Gold labels were counted, and coordi-
nates were assigned to each feature. Interparticle
distances were calculated using a nearest neighbor
(nn) distance algorithm. (A) nn distance values were
calculated for each image, and the data of several
independent experiments were pooled. Subse-
quently, the nn distances were divided into three
classes: 0–50, 50–100, and100 nm, and the percent-
age of nn distance values falling into each class was
plotted. (B) The partitioning of gold labels in clusters
of various size (i.e., number of particles/cluster) was
also quantified. Clusters were defined when gold
particles were 50 nm apart from a neighboring
particle. The percentage of gold particles involved in
the formation of a certain cluster size was calculated.
The insets are two representative processed digital
images, where each type of cluster is shown in a
different color. One representative experiment out of
three is shown.
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primed LFA-1 molecules can be observed at the contact area
between MOs and T-cells from 270 to 810 s after contact
initiation. Importantly, the presence of neither TS2/4 nor
NKI-L16 significantly increases binding of MOs (nor of DCs)
to ICAM-1–coated beads (our unpublished data), suggest-
ing that the cell–cell interaction cannot be attributed to the
presence of these Abs. When the interaction between MOs
and T-cells occurred in presence of the blocking mAb NKI-
L15, hardly any conjugate was observed, and no recruitment
of primed LFA-1 could be detected (Figure 7B).
Finally, we quantified the recruitment of primed LFA-1
fraction (L16 positive) with respect to the total LFA-1 (la-
beled by TS2/4 or NKI-L15) by calculating the recruitment
index (RI), which we defined as the fluorescence intensity at
the contact area divided by the fluorescence intensity of the
whole cell (Figure 8). Figure 8A shows that primed LFA-1 is
significantly enriched at the cell–cell contact site with re-
spect to the total LFA-1 fluorescence signal. In presence of
the blocking Ab NKI-L15, no clear interaction between MOs
and T-cells could be observed, and no specific recruitment of
LFA-1 was observed at the cell–cell contact (Figure 8B).
Together, these results indicate that ligand-independent
primed LFA-1 nanoclusters are preformed LFA-1 platforms
rapidly recruited to the cell–cell contact where they fuse to
originate micrometer-sized macroclusters. The LFA-1 mac-
roclusters are engaged in ligand binding and specifically
interact with the cytoskeleton via talin.
DISCUSSION
The leukocyte specific 2 integrin LFA-1 regulates cell adhe-
sion, migration, and immunological synapse formation. Here
Figure 5. Resting and primed ligand-independent LFA-1
nanoclusters are expressed on the MO plasma membrane.
(A) MOs were labeled as described in Figure 4, and the
distribution patterns obtained with different anti-L mAbs
were compared. (B) Quantitative analysis of the distribu-
tion of gold particle labeling LFA-1 was performed as
described in Figure 4B, and gold labels detected per m2
were counted. (C) Also, the number of clusters per m2
was calculated. (D) The percentage of nn distance values
falling into each class was plotted. Data are the mean of
three independent experiments SD. (E) The partitioning
of gold labels in clusters of various size was also quantified
and compared between the mAbs. Clusters were defined
as described in Figure 4B. One representative experiment
out of three is shown. Scale bar, 200 nm.
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we demonstrate for the first time, exploiting high-resolution
TEM and spatial-point pattern analysis, that LFA-1–mediated
cell adhesion is directly correlated with submicrometer-sized
avidity changes of LFA-1 when MOs differentiate into DCs.
On DC LFA-1 Is Inactive
MOs can readily differentiate into antigen-presenting DC
upon reverse transmigration of endothelial monolayers
(Randolph et al., 1998) or when cultured in vitro in presence
of GM-CSF and IL-4 (Romani et al., 1996). Therefore, by
using MOs and moDCs instead of LFA-1 transfectants we
followed changes in the behavior of endogenous adhesion
receptors in a semiphysiological system. Moreover, moDC
are currently manipulated ex vivo for antitumor and antivi-
ral therapy (Figdor et al., 2004). Detailed characterization of
the migratory and adhesive properties of moDCs is there-
fore very important and can have direct consequences for
the currently executed clinical trials.
Although MOs and DCs express equivalent levels of LFA-1,
there is a marked difference in LFA-1 activation state on the
two cell types (Figure 1A). High-resolution mapping of LFA-1
cell surface distribution patterns by TEM and quantitative spa-
tial point pattern analysis now revealed that on DCs the resting
LFA-1 molecules are randomly distributed on the cell mem-
brane as single features (Figure 3). Similar observations were
made on K562 cells transfected with LFA-1 (K-LFA-1), which
do not bind ICAM-1 and exhibit a random cell surface distri-
bution of LFA-1 (our unpublished data). These data are in
agreement with recent observation that the absence of FRET-
detectable microclustering corresponds with lack of binding
activity on K-LFA-1 cells (Kim et al., 2004).
Crystallography, NMR, and negative stain EM showed dif-
ferent conformational states of integrin fragments, revealing
structural rearrangements of both  and  subunits upon acti-
vation (Beglova et al., 2002; Takagi et al., 2002; Xiao et al., 2004).
In the low-affinity conformation, the headpiece of the integrin
faces down toward the cell membrane; in the high-affinity
conformation, the headpiece extends upward. This molecular
switch occurs at the “genu” of the integrin subunits (Takagi
and Springer, 2002). In particular, the  subunit leg has been
shown to extend at the Ca2-dependent epitope near the
thigh–genu interface (Xie et al., 2004). This epitope appears
only in the extended conformation and in the case of L is
specifically recognized by the conformation-sensitive mAb
NKI-L16 (Keizer et al., 1988; Xie et al., 2004). We have shown
that LFA-1–binding capacity is directly correlated to the ex-
pression of this epitope (Figure 1B). Because in the L inactive
conformation the L16 epitope is shielded from Ab recognition,
the complete lack of L16 epitope on DCs suggests that all
LFA-1 molecules are in the “off,” i.e., bent conformation. A
recent publication of van Gisbergen et al. (2005) suggests that
on DCs inactive LFA-1 may be triggered upon interaction of
DCs with T-cells (van Gisbergen et al., 2005). Further studies
are needed to unravel the exact signaling pathways that may
trigger resting LFA-1 molecules on DCs.
LFA-1 Nanoclusters Are Either Resting or Primed
On MOs, LFA-1 is organized in primed nanoclusters (L16
positive) and resting nanoclusters (L16 negative). Because
no apparent differences were found in gold particles prox-
imity or cluster size when comparing resting and primed
nanoclusters (Figure 5), we hypothesize that clustering and
Figure 6. The primed LFA-1 molecules colocalize with ICAM-1 and talin at the cell–cell contacts. (A) MOs were allowed to adhere onto
PLL-coated glass coverslips for 30 min at 37°C. After extensive washing with cold PBS, cells were incubated with TS2/4 (red) and NKI-L16
(green) on ice for 30 min to label total LFA-1 and primed LFA-1, respectively. Unbound Abs were removed, and cells were fixed with 2%
PFA. Isotype specific Alexa-conjugated goat anti-mouse Abs were added. The cells were analyzed by confocal microscopy, and colocalization
is indicated in yellow. (B) MOs were seeded at high density on PLL-coated glass coverslips and labeled as described for A. Total LFA-1 is
shown in green and primed fraction in red. Colocalization is indicated in yellow in the merged picture. Subsequently, triple labeling for total
LFA-1 (green), primed LFA-1 (blue), and various interactors (red), such as the ligand ICAM-1 (C), talin (D), cytohesin-1 (E), and RapL (F),
was performed on high-density seeded MOs. Colocalization is shown in the merged pictures. Bar, 10 m, unless otherwise indicated.
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priming represent two distinct events and LFA-1 molecules
must all adopt either the bent inactive or the extended
primed conformation within a nanocluster. The underlying
mechanism remains unknown, but it is tempting to specu-
late that a cooperative effect between the packed LFA-1
molecules may exist. Recently, Nishiuchi et al. (2005) de-
Figure 7. The primed LFA-1 nanoclusters are
rapidly recruited at the MO–T-cell contact. (A)
MOs were allowed to adhere at low density
onto a glass coverslip for 30 min at 37°C. After
washing with PBS, MOs were labeled with
anti-aL mAbs NKI-L16 and TS2/4, as de-
scribed in Materials and Methods. After removal
of unbound Abs, Jurkat T-cells were added.
The formation of spontaneous conjugates be-
tween MOs and T-cells was followed at 37°C
with a Zeiss LSM 510 microscope. (B) In pres-
ence of the blocking mAb NKI-L15, the num-
ber of conjugates was lower, and no enrich-
ment of NKI-L16–positive LFA-1 molecules at
the cell–cell contact was observed.
Figure 8. Quantification of the recruitment of the
primed LFA-1 fraction at the MO–T-cell contact site. As
shown in the cartoon, the recruitment index (RI) of each
Ab was defined as the fluorescence intensity at the
contact site divided by the fluorescence intensity of the
whole cell. Data in A and B are referred to the images
shown in Figure 7, A and B, respectively, and are rep-
resentative of multiple cells in three independent exper-
iments.
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scribed the role of the tetraspanin CD151 in modulating the
integrin 31 adhesiveness by stabilizing its active confor-
mation through physical interaction. Other tetraspanins
were shown to be involved in the regulation of LFA-1 ad-
hesiveness (Shibagaki et al., 1999; Van Compernolle et al.,
2001). We are currently investigating the role of these tetra-
spanins in the formation of LFA-1 nanoclusters.
The arrangement of LFA-1 in nanoclusters may also guar-
antee an efficient binding and rebinding of LFA-1 to the
ICAM-1 homodimers expressed on the endothelium. Bio-
chemical studies showed that a divalent LFA-1 is the mini-
mum configuration for forming efficient bonds with ICAM-1
(Sarantos et al., 2005). LFA-1 nanoclusters may further in-
crease the likelihood of LFA-1 binding to ICAM-1. Shamri et
al. (2005) recently showed that on rolling lymphocytes
LFA-1 activation occurs locally and abruptly and that prim-
ing of LFA-1 molecules (i.e., L16 epitope induction) is a
prerequisite for ICAM-1–induced activation of the  subunit
I-domain.
LFA-1 Nanoclusters Are Formed Independently of Ligand
Binding
It has long been debated whether clustering of integrins trig-
gers or rather results from ligand binding. Here, we present
“snapshots” of the MO cell membrane, in the absence of ligand
binding, where LFA-1 shows a well-defined clustered distribu-
tion pattern. Because integrin activity on circulating leukocytes
is up-regulated within seconds (Shamri et al., 2005), organiza-
tion of LFA-1 in small predefined nanoclusters would favor
instant interaction with the endothelial surface. Carman and
colleagues showed that on MO linear clusters of LFA-1 colo-
calize with ICAM-1–containing microvilli on the endothelium
before MO extravasation (Carman and Springer, 2004). Our
observations extend their findings and suggest that on MO cell
surface, preformed LFA-1 nanoclusters may facilitate or accel-
erate the interaction of MOs with these endothelial ICAM-1–
enriched projections.
Although it was suggested that localized clustering of LFA-1
at the cell surface might simply result from previous encoun-
ters of LFA-1 with ICAM ligands exposed by adjacent cells
(Kim et al., 2004), our current findings suggest a more complex
mechanism. Kim et al. (2004) showed that only binding of
multimeric ligand (i.e., ICAM-1Fc/Anti-IgA complexes) to
LFA-1–induced FRET-detectable microclustering on K-LFA-1
cells. We observed that when MOs are allowed to adhere at
low density to prevent cell contact with ICAM-1 molecules
from adjacent cells, nanoclusters are still present. Moreover,
inhibition of LFA-1/ICAMs interactions in cis does not alter
LFA-1 nanocluster organization (Supplementary Figure 3).
Furthermore, DCs, which do not have LFA-1 nanoclusters,
cannot be induced to form LFA-1 aggregates, even when cul-
tured at high cell density (our unpublished data). However, we
do not exclude that upon ligand binding a further increase in
receptor packing might occur within the LFA-1 nanoclusters
that would induce FRET-detectable changes in intradomain
receptor proximity. Further high-resolution analysis of the in-
tegrin molecules within these assemblies is needed to provide
detailed insight in the molecular and spatial organization of
LFA-1 nanoclusters.
LFA-1 Macroclusters Derive from the Recruitment of
Pre-existing Nanoclusters
We investigated the interaction between MOs double-la-
beled for LFA-1 (NKI-L16 and TS2/4) and unlabeled ICAM-
1–bearing T-cells by live imaging and quantified LFA-1
accumulation at the cell–cell contact (Figures 7 and 8). The
RI of primed LFA-1 molecules at the MO–T-cell contact site
is significantly higher than the RI of the total LFA-1 (Figure
8). This indicates that the preformed L16-positive nanoclus-
ters act as “primed” scaffolds of LFA-1 molecules that
readily bind the ligand. These scaffolds are recruited at the
contact site where larger micrometer-sized macroclusters
are subsequently formed (Figure 9).
Further adhesion strengthening might result from inter-
actions of LFA-1 cytoplasmatic tails with known 2- or
L-interacting cytoplasmic regulatory proteins. We could
clearly detect a specific enrichment of talin at the cell–cell
interface where LFA-1 binds to ICAM-1 (Figure 6D). Strik-
ingly, neither interactions with cytohesin-1 nor RapL were
observed (Figure 6, E and F), suggesting that the mecha-
nism(s) regulating LFA-1 activity on MOs may differ from
Figure 9. Major changes in LFA-1 avidity
and adhesiveness occur during DC develop-
ment. This cartoon summarizes the major phe-
notypical changes observed on DCs compared
with their precursor MO. Although on imma-
ture DCs, LFA-1 is unable to bind to its li-
gands, is randomly distributed at the cell sur-
face and completely excluded from the lipid
rafts, on MO LFA-1 is organized in well-
defined submicrometer sized nanoclusters.
LFA-1 nanoclusters reside in lipid rafts but
differ in terms of activation state: a fraction is
primed and express the L16 epitope, the rest is
in a bent resting conformation. By interaction
with ICAM-1–bearing cells, the primed nano-
clusters are recruited at the contact site,
generating micrometer-sized macroclusters.
There, LFA-1 binds to the counterreceptor
ICAM-1 and establishes additional interac-
tions with the cytoplasmic protein talin. In cell
types other than MO, other regulators, such as
RapL, might be then recruited from the cyto-
plasm and further strengthen binding and
modulate signaling.
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those on T-cells, where both proteins were found to modu-
late LFA-1 function (Geiger et al., 2000; Katagiri et al., 2003).
Our observation that nanocluster formation does not require
interaction with talin, whereas ligand-engaged macroclusters
fully colocalize with talin, is in agreement with findings of
Shamri et al. (2005). They observed that LFA-1 tethering to
low-density ICAM-1 under shear flow does not require intact
talin, whereas at increasing ICAM-1 density, the contribution
of talin also increases (Shamri et al., 2005). In addition, Xie et al.
(2004) have mapped the L16 epitope by using a chimeric con-
struct where extracellular  and  chains were fused to the
same transmembrane anchoring domain of platelet-derived
growth factor receptor. This construct allows the chimeric pro-
tein to be displayed on the cell surface but lacks the integrin
cytoplasmic tail motifs that modulate the interaction with talin.
Therefore, the formation of ligand-independent primed nano-
clusters does not require interaction between LFA-1 and talin,
whereas strengthening of cell–cell contacts is specifically sup-
ported by the presence of talin.
LFA-1 Nanoclusters and Lipid Rafts
The organization of membrane receptors in microdomains is
often associated with their colocalization with lipid rafts. On
T-cells, only active LFA-1 was found to reside in lipid rafts
(Leitinger and Hogg, 2002). Interestingly, our studies on MOs
show that both primed and resting LFA-1 nanoclusters colo-
calize with lipid rafts, indicating that neither clustering nor
association with lipid rafts per se are sufficient for priming of
LFA-1. However, on DCs random inactive LFA-1 is completely
excluded by the lipid raft environment (Figure 2). The mecha-
nism by which integrins are recruited into lipid rafts remains
unclear. Because no clear lipid modification (such as myristoyl-
ation or palmitoylation) has been reported for integrin mole-
cules, the differentiated association of LFA-1 with lipid rafts is
most likely regulated by complex formation between the inte-
grin and other as yet undefined membrane proteins.
The organization of LFA-1 in nanoclusters residing in lipid
rafts may also explain why HIV-1 particles bearing host-de-
rived ICAM-1 are efficiently spread by MOs but not by moDCs
(Bounou et al., 2004). Recently, we made similar observations
for DC-SIGN, which binds and internalizes HIV-1 particles
only when it is organized in submicrometer-sized microdo-
mains, not when randomly distributed (Cambi et al., 2004).
Therefore, LFA-1 nanoclusters on MOs may be exploited by
host-derived ICAM-1-bearing HIV-1 through a similar mech-
anism using LFA-1 nanoclusters as docking platforms.
CONCLUSIONS
We demonstrated that phenotypical changes occurring during
development of precursor cells such as MOs into DCs involve
also rearrangement of receptor organization at the cell surface.
By using high resolution microscopy, we visualized distinct
stages of integrin avidity: random inactive molecules, ligand-
independent nanoclusters, and ligand-triggered macroclusters.
Our findings reveal a novel mechanism to regulate integrin
function. Well-defined pre-existing nanoclusters of LFA-1
equip the cell with a machinery to respond instantly when
action is required, such as binding to endothelium or interact-
ing with other leukocytes. The absence of these nanoclusters on
human moDCs explains why these cells lack the capacity to
bind ICAM-1 despite significant expression of LFA-1. The
present challenge is to better understand the mechanism that
regulates the submicrometer-sized avidity changes of LFA-1
during DC development.
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